-
Mashup Score: 0Social Media and Myeloproliferative Neoplasms (MPN): Analysis of Advanced Metrics From the First Year of a New Twitter Community: #MPNSM - 3 year(s) ago
The social media platform Twitter has provided the hematology/oncology community with unprecedented, novel methods of interpersonal communication and increased ability for the dissemination of important updates in a rapidly moving field. The advent, and subsequent success, of disease-specific Twitter communities have further enabled interested healthcare stakeholders to become quickly organized…
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 10Current Approach to Managing Patients with Newly Diagnosed High-Risk Multiple Myeloma - 3 year(s) ago
Purpose of Review With rapid advances in the therapeutic landscape and biological insights in multiple myeloma, it is critical to identify and strategically manage high-risk patients to achieve best outcomes with currently available drugs. The purpose of this review is to summarize the management of high-risk myeloma with a focus on recent advances in the field. Recent Findings The most widely…
Categories: Hem/Oncs, Latest HeadlinesTweet-
Our review on how to manage 𝑯𝒊𝒈𝒉-𝑹𝒊𝒔𝒌 #Myeloma with a deluge of new data on quadruplets and #MRD https://t.co/mZ57Mf2Krl #mmsm #bmtsm https://t.co/GtmHIMwKfX
-
-
Mashup Score: 3Tweeting from the Bench: Twitter and the Physician-Scientist Benefits and Challenges - 3 year(s) ago
Purpose of Review Social media platforms such as Twitter are increasingly utilized to interact, collaborate, and exchange information within the academic medicine community. However, as Twitter begins to become formally incorporated into professional meetings, educational activities, and even the consideration of academic promotion, it is critical to better understand both the benefits and…
Categories: Hem/Oncs, Latest HeadlinesTweet-
Tweeting from the Bench: Twitter and the Physician-Scientist Benefits and Challenges [Nov 11, 2020] @JessicaLittleMD @romeerizwan Current Hematologic Malignancy Reports https://t.co/M1hHiSa44w PDF: https://t.co/npoH3GhrSy #socialoncology
-
-
Mashup Score: 2The Democratization of Scientific Conferences: Twitter in the Era of COVID-19 and Beyond - 3 year(s) ago
Purpose of Review The coronavirus disease 2019 (COVID-19) pandemic has had profound impacts upon scientific discourse in our field, most prominently through the abrupt transition of malignant hematology conferences to all-digital formats. These virtual components will likely be incorporated into future iterations of these conferences even as in-person attendance is reincorporated. In this review,…
Categories: Hem/Oncs, Latest HeadlinesTweet-
👉👉👉Our new paper just out in PubMed led by superstar MDs @RahulBanerjeeMD & @amarkelkar The Democratization of Scientific Conferences:Twitter in the Era of COVID-19 & Beyond | @hemedoc @BldCancerDoc @doctorpemm https://t.co/pX0hEDEmNh
-
-
Mashup Score: 1Social Media and Internet Resources for Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) - 3 year(s) ago
The incorporation of Internet resources and the use of social media among patients, clinicians, advocates, and researchers in the field of hematology and oncology are growing in importance. Utilization of online information sharing is rising, especially among those involved in rare blood cancer fields, which have generally featured a paucity of reliable, updated information. In particular,…
Categories: Hem/Oncs, Latest HeadlinesTweet-
Social Media & Internet Resources for Blastic Plasmacytoid Dendritic Cell Neoplasm #BPDCN [Aug 4, 2016] @doctorpemm et al. https://t.co/SnAMtMBegw
-
-
Mashup Score: 1Novel Pathways and Potential Therapeutic Strategies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): CD123 and Beyond - 3 year(s) ago
Access options Buy single article Instant access to the full article PDF. US$ 39.95 Tax calculation will be finalised during checkout. …
Categories: Hem/Oncs, Latest HeadlinesTweet-
Novel Pathways and Potential Therapeutic Strategies for Blastic Plasmacytoid Dendritic Cell Neoplasm (#BPDCN): CD123 and Beyond [10/24/17] @doctorpemm CHMR https://t.co/IUsvpCCWAI
-
-
Mashup Score: 2
Purpose of Review Social media engagement by medical professionals with varied background subspecialties has steadily gained popularity in recent years. As a heavily visual discipline, pathology has been able to leverage social media platforms for trainee education, curbside and official consultations, interdisciplinary communication, and interactions among medical professionals and patient…
Categories: Hem/Oncs, Latest HeadlinesTweet-
Social Media for Hematopathologists: Medical Practice Reinvented—#Hemepath | SpringerLink || @SibaElHussein @KirillLyapichev @evemariecrane @KMirza @JoeKhouryMD @sanamloghavi | #leusm #MPNSM #endcancer https://t.co/j8dzboX7oe
-
-
Mashup Score: 5Antibody-Based Treatment Approaches in Multiple Myeloma - 3 year(s) ago
Purpose of Review The field of multiple myeloma treatment has entered a new era with antibody-based approaches in clinical practice. In this review, we focus on the clinical approaches of utilizing antibody-based modality, specifically monoclonal antibodies, antibody-drug conjugates, and bispecific T-cell antibodies in the treatment of multiple myeloma. Recent Findings Three monoclonal antibodies…
Categories: Hem/Oncs, Latest HeadlinesTweet-
Check out our review on antibody based therapy in myeloma. We summarize latest data on monoclonal antibodies, ADCs (bela-maf) and bispecific antibodies in this review. #mmsm https://t.co/wapkmowD1s https://t.co/eGWkJUG1XU
-
-
Mashup Score: 0
Purpose of Review Social media engagement by medical professionals with varied background subspecialties has steadily gained popularity in recent years. As a heavily visual discipline, pathology has been able to leverage social media platforms for trainee education, curbside and official consultations, interdisciplinary communication, and interactions among medical professionals and patient…
Categories: Hem/Oncs, Latest HeadlinesTweet-
Social Media for Hematopathologists: Medical Practice Reinvented -- #Hemepath [Oct 30, 2020] S. El Hussein et al. CHMR https://t.co/YWjGjY5Pc4 #oncopath
-
-
Mashup Score: 2Tweeting from the Bench: Twitter and the Physician-Scientist Benefits and Challenges - 3 year(s) ago
Social media platforms such as Twitter are increasingly utilized to interact, collaborate, and exchange information within the academic medicine community. However, as Twitter begins to become formally incorporated into professional meetings, educational activities, and even the consideration of academic promotion, it is critical to better understand both the benefits and challenges posed by this…
Categories: Hem/Oncs, Latest HeadlinesTweet-
Tweeting from the Bench: Twitter and the Physician-Scientist Benefits and Challenges [Nov 11, 2020] @JessicaLittleMD @romeerizwan Current Hematologic Malignancy Reports https://t.co/M1hHiSa44w PDF: https://t.co/npoH3GhrSy #socialoncology HT @DrChoueiri
-
Social Media & MPN: Advanced Metrics From 1st Yr of a New Twitter Community: #MPNSM [8/4/16] @doctorpemm et al. CHMR https://t.co/aG7L2JbB6r